Baxalta | Evaluate

Gamma-delta work makes cautious inroads into the clinic

January 17, 2017

M&A in 2016: Pause for breath in a shifting market

January 06, 2017

Snippet roundup: J&J and Shire make some deals, but disappointments beckon for Arena and Inotek

December 03, 2016

Ash – Spark strengthens case for haemophilia gene therapy

November 17, 2016

Gilead’s myelofibrosis stumble leaves way clear for Jakafi

October 17, 2016

M&A gives signs of reverting to the mean

September 28, 2016

Shire cedes biosimilar field

September 14, 2016

Roche to topple Novartis as industry’s biggest seller

September 01, 2016

Medtech mergers still the driving force behind jobs changes

August 05, 2016

Snippet roundup: Biogen buy rumours, CVS cuts and Spark gains on Shire's loss,

July 12, 2016

Approval makes Xiidra the apple of Shire’s eye

Load More